Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility

  • Cryopreservation, Journal Articles

Kunkele A, Taraseviciute A, Finn L, Johnson A, et al. Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility Clin Cancer Res; 23(2) January 15, 2017 DOI: 10.1158/1078-0432.CCR-16-0354

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.

Accept & close